Breast cancer subtype intertumor heterogeneity: MRI‐based features predict results of a genomic assay

To investigate the association between a validated, gene‐expression‐based, aggressiveness assay, Oncotype Dx RS, and morphological and texture‐based image features extracted from magnetic resonance imaging (MRI).

[1]  Joseph P. Costantino,et al.  Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20 , 2011, Breast Cancer Research and Treatment.

[2]  R. Bast,et al.  American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Felipe C Geyer,et al.  Molecular Classification of Estrogen Receptor-positive/Luminal Breast Cancers , 2012, Advances in anatomic pathology.

[4]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[5]  H. Bonnefoi,et al.  Correlation between imaging and molecular classification of breast cancers. , 2013, Diagnostic and interventional imaging.

[6]  M. Cronin,et al.  Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Giger,et al.  Volumetric texture analysis of breast lesions on contrast‐enhanced magnetic resonance images , 2007, Magnetic resonance in medicine.

[8]  Janet Waters,et al.  MRI for breast cancer screening, diagnosis, and treatment , 2011, The Lancet.

[9]  Wei Tse Yang,et al.  Identification of Intrinsic Imaging Phenotypes for Breast Cancer Tumors: Preliminary Associations with Gene Expression Profiles , 2015 .

[10]  Manuela Pereira,et al.  3D Lacunarity in Multifractal Analysis of Breast Tumor Lesions in Dynamic Contrast-Enhanced Magnetic Resonance Imaging , 2013, IEEE Transactions on Image Processing.

[11]  Rohit Bhargava,et al.  Histopathologic variables predict Oncotype DX™ Recurrence Score , 2008, Modern Pathology.

[12]  Peter Gibbs,et al.  Texture analysis in assessment and prediction of chemotherapy response in breast cancer , 2013, Journal of magnetic resonance imaging : JMRI.

[13]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[15]  H. Ashamalla,et al.  Routine Histopathologic Characteristics Can Predict Oncotype DXTM Recurrence Score in Subsets of Breast Cancer Patients , 2013, Cancer investigation.

[16]  Aleix Prat Aparicio.  Comprehensive molecular portraits of human breast tumours , 2012 .

[17]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[18]  Maciej A Mazurowski,et al.  Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging. , 2014, Radiology.

[19]  C. Kuhl,et al.  Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? , 1999, Radiology.

[20]  J. Cuzick,et al.  Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: recurrence score alone and integrated with pathologic and clinical factors. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Elizabeth A Morris,et al.  Diagnostic breast MR imaging: current status and future directions. , 2010, Magnetic resonance imaging clinics of North America.

[22]  L. Turnbull,et al.  Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy. , 2009, European journal of radiology.

[23]  Yuanjie Zheng,et al.  STEP: Spatiotemporal enhancement pattern for MR-based breast tumor diagnosis , 2009 .

[24]  Jeon-Hor Chen,et al.  Computer-aided diagnosis of mass-like lesion in breast MRI: Differential analysis of the 3-D morphology between benign and malignant tumors , 2013, Comput. Methods Programs Biomed..

[25]  Jack Cuzick,et al.  Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  M. Jacobs.  Multiparametric magnetic resonance imaging of breast cancer. , 2009, Journal of the American College of Radiology : JACR.

[27]  Joseph O Deasy,et al.  CERR: a computational environment for radiotherapy research. , 2003, Medical physics.

[28]  A. Gown,et al.  Routine pathologic parameters can predict Oncotype DXTM recurrence scores in subsets of ER positive patients: who does not always need testing? , 2011, Breast Cancer Research and Treatment.

[29]  Issam El-Naqa,et al.  Exploring feature-based approaches in PET images for predicting cancer treatment outcomes , 2009, Pattern Recognit..

[30]  W. Han,et al.  Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation. , 2013, Radiology.

[31]  S. Shak,et al.  A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients , 2006, Breast Cancer Research.

[32]  Robert B Livingston,et al.  Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. , 2010, The Lancet. Oncology.

[33]  Min-Ying Su,et al.  Prediction of malignant breast lesions from MRI features: a comparison of artificial neural network and logistic regression techniques. , 2009, Academic radiology.

[34]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[35]  S. Paik,et al.  Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  H. Eskola,et al.  Characterization of breast cancer types by texture analysis of magnetic resonance images. , 2010, Academic radiology.